22 May 2013
Keywords: sandoz, gets, fda, approval, omnitrope, generics, division
Article | 08 September 2008
Sandoz, the generics division of Swiss drug major Novartis, has received US Food and Drug Administration approval for its Omnitrope ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2008
21 May 2013
© 2013 thepharmaletter.com